Jahreskongress

Congrès Annuel

Annual Meeting

Interlaken

Congress Centre Kursaal Interlaken

12.-13.September 2019

      
Menu

Programme

Thursday, 12.9.2019

0830-1000
Theatersaal
IBD Treatment 2019 (sponsered by MSD)
Stephan Brand, St. Gallen    Gerhard Rogler, Zürich    
0830-0900
Theatersaal
The role of Vedolizumab in real life IBD treatment
Frank Seibold, Bern    
0900-0930
Theatersaal
JAK Inhibitors: Benefits and risks in ulcerative colitis patients
Pierre Michetti, Lausanne    
0930-1000
Theatersaal
Which drug to choose: Evidence based treatment decisions in a landscape of growing option
Britta Siegmund, Berlin    
0830-1000
Kongresssaal
New Challenges in Hepatology
Andrea De Gottardi, Bern    Christine Bernsmeier, Basel    
0830-0845
Kongresssaal
Immunotherapy and HCC
Markus Heim, Basel    
0845-0900
Kongresssaal
Primary Sclerosing Cholangitis and cholangiocarcinoma surveillance
Joachim Mertens, Zürich    
0900-0915
Kongresssaal
Cirrhosis - a temporary disease?
Annalisa Berzigotti, Bern    
0915-0930
Kongresssaal
Acute alcoholic hepatitis: who to transplant?
Laurent Spahr, Genève    
0930-0945
Kongresssaal
Hepatitis B - to stop or not to stop therapy?
Darius Moradpour, Lausanne    
0945-1000
Kongresssaal
New therapies for NASH
Nicolas Goossens, Genève    
0830-1000
Saal Brünig
SGVC: Peritonitis and Abdominal Sepsis
Markus K. Müller, Frauenfeld    Dieter Hahnloser, Lausanne    
0830-0855
Saal Brünig
Damage Control Surgery in Peritonitis
Martin Bolli, Basel    
0855-0920
Saal Brünig
„Just for the sofa? The Value of Scores in Abdominal Sepsis“
Daniel M. Frey, Wetzikon    
0920-1000
Saal Brünig
Antibiotic Treatment of Peritonitis
Christian Eckmann, Peine    
1000-1030
Exhibition Area
Coffee break
1030-1200
Theatersaal
SGG-SGVC-Joint Session (sponsered by Takeda Pharma AG): Prize winner / surgery in cirrhotic patients
Peter Bauerfeind, Zürich    Beat Müllhaupt, Zürich    Jean-Louis Frossard, Genève    Antonio Nocito, Baden    
1030-1050
Theatersaal
Prizewinners
1050-1110
Theatersaal
Surgery in Cirrhotic Patients: Risk stratification and presurgical considerations
David Semela, St. Gallen    
1110-1130
Theatersaal
General surgery in cirrhotic patients
Guido Beldi, Bern    
1130-1150
Theatersaal
Hepatic surgery in cirrhotic patients
Christian Toso, Genève    
1200-1230
Exhibition Area
Lunch break
1230-1315
Theatersaal
Lunch Symposium Pfizer: Xeljanz® (Tofacitinib): A practical guide to JAK Inhibition in UC
1230-1315
Kongresssaal
Lunch Symposium Janssen-Cilag AG: Learning biological use in CD from international experts
1230-1315
Saal Brünig
Lunch Symposium Takeda Pharma AG: Comparative Evidence in Ulcerative Colitis - the VARSITY Study: Vedolizumab vs Adalimumab
1230-1315
Saal Harder
Lunch Symposium AbbVie: Hepatitis C Elimination by 2030. Gastroenterologists Evolving Role
1330-1500
Theatersaal
IBD: Fistula therapy and free communications
Pierre Michetti, Lausanne    Andrew Macpherson, Bern    
1330-1340
Theatersaal
The intra-individual Variability of Fecal Calprotectin in patients with GI-symptoms
Seraina Netzer, Bern    
1340-1350
Theatersaal
Isoproterenol activates gut-liver-axis: effects on intestinal mucus and vascular barrier as entry sites
Marcel Sorribas, Bern    
1350-1400
Theatersaal
Obesity is frequent in inflammatory bowel disease patients and associated with higher disease activity in Crohn's disease, but not ulcerative colitis
Thomas Greuter, Zürich    
1400-1410
Theatersaal
Efficacy of Etrolizumab in patients with moderate to severe UC who had failed TNF Antagonist Therapy (HICKORY)
Frank Seibold, Bern    
1410-1420
Theatersaal
LPA-induced GPR35 signaling in macrophages resulted in reduced TNF production associated with decreased intestinal corticosterone synthesis
Berna Kaya, Basel    
1420-1430
Theatersaal
Is IBDialog monthly a helpful tool in daily clinical practice?
Lisa Schmitz, Wattwil    
1430-1500
Theatersaal
Fistula therapy with mesenchymal stem cells: First experiences and perspectives: case presentations
Alain Schoepfer, Lausanne    Luc Biedermann, Zürich    Matthias Turina, Zürich    
1330-1500
Kongresssaal
Hereditary colon cancer syndroms and free communications
Dieter Hahnloser, Lausanne    Reiner Wiest, Bern    
1330-1400
Kongresssaal
Hereditary colon cancer syndroms
Gabriela Möslein, Wuppertal    
1400-1410
Kongresssaal
Aspirin suppresses age-associated and colon cancer relevant DNA methylation changes in the healthy colon
Faiza Noreen, Basel    
1410-1420
Kongresssaal
Liver fibrosis screening in patients undergoing a screening colonoscopy (FIB-SCREEN): feasibility and preliminary results of a prospective study
Yves Flattet, Genève    
1420-1430
Kongresssaal
Drug-induced liver toxicity in a prospective cohort of cancer patients receiving immune checkpoint inhibitors
Luka Flatz, St. Gallen    
1430-1440
Kongresssaal
Endoscopic full-thickness resection for early colorectal cancer
Patrick Aepli, Luzern    
1440-1450
Kongresssaal
Pain after FTRD in the upper and lower GI tract –a single center experience
Henriette Heinrich, Zürich    
1450-1500
Kongresssaal
Beta6-Integrin – A novel Serum Marker predicting overall Survival in Pancreatic Adenocarcinoma
Bernhard Morell, Zürich    
1330-1500
Saal Brünig
SGVC: Endocrine Surgery
Frédéric Triponez, Genève    Stefan Wildi, Zürich    
1330-1350
Saal Brünig
Malignant Thyroid Neoplasms
Reto Kaderli, Bern    
1350-1410
Saal Brünig
Benign Thyroid Diseases
Thomas Clerici, St. Gallen    
1410-1430
Saal Brünig
Diseases of the Parathyroid Gland
Diana Vetter, Zürich    
1430-1450
Saal Brünig
Complications in Thyroid and Parathyroid Surgery
Frédéric Triponez, Genève    
1500-1530
Exhibition Area
Coffee break
1530-1700
Theatersaal
Endoscopy and free communications
Lukas Degen, Basel    Robert Bründler, Luzern    Magnus Paul Schneider, Zürich    
1530-1540
Theatersaal
Eosinophilic esophagitis-like disease with lack of significant esophageal eosinophilia: Description of a new disease entity
Thomas Greuter, Zürich    
1540-1550
Theatersaal
IL-20 cytokine signaling modulates eosinophilic esophagitis
Tanay Kaymak, Basel    
1550-1600
Theatersaal
Endoscopic Vacuum Therapy by EsoSponge® : treatment of oesogastroduodenal leakage. Who‘s the best patient?
Philippe Bichard, Genève    
1600-1610
Theatersaal
Endoscopic Ultrasound-guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: a retrospective single center study
Toni Trosic-Ivanisevic, Lausanne    
1610-1620
Theatersaal
Five-year audit of endoscopic submucosal dissection (ESD) in daily clinical practice
Dominik Pytlik, Bern    
1620-1630
Theatersaal
Feasibility of ileal intubation in colonoscopy with Endocuff: a prospective open label comparison
Mikael Sawatzki, St. Gallen    
1630-1700
Theatersaal
Fundoplication and bariatric surgery: when does endoscopy replace surgery?
Thomas Rösch, Hamburg    
1530-1700
Kongresssaal
Neurogastroenterology and free communications
Radu Tutuian, Solothurn    Joachim Mertens, Zürich    Daniel Pohl, Zürich    
1530-1600
Kongresssaal
What to do after negative diagnostic procedures
Frank Zerbib, Bordeaux    
1600-1610
Kongresssaal
Clinical outcome after single EsoFLIP dilation in patients with achalasia
Larissa Schnurre, Zürich    
1610-1620
Kongresssaal
Functional Luminal Imaging Probe (EndoFLIP®) unveils endoscopically non-visible esophageal strictures in dysphagia patients
Ioannis Linas, Bern    
1620-1630
Kongresssaal
A Specific Subtype of Hepatitis E Virus Circulates Widely in Switzerland
Jérôme Gouttenoire, Lausanne    
1630-1640
Kongresssaal
Liver function assessment by 13C-methacetin test before and after placement of a transjugular portosystemic shunt: A prospective pilot study
David Semela, St. Gallen    
1640-1650
Kongresssaal
Real-World Effectiveness and Safety of Glecaprevir plus Pibrentasvir in HCV: Postmarketing Observational Data from Switzerland
Nasser Semmo, Bern    
1650-1700
Kongresssaal
Large-scale screening is not useful to identify individuals with hepatitis B or C virus infection: Final results of a Swiss prospective study
Aicha Trabelsi, Lausanne    
1530-1700
Saal Brünig
SGVC: Parietology
Diego De Lorenzi, Grabs    Franc Hetzer, Uznach    
1530-1550
Saal Brünig
TIPP, TAPP, TEP what else?
Christian Helbling, Uznach    
1550-1610
Saal Brünig
Open Repair of Incisional Hernia
Dominique Sülberg, Baden    
1610-1630
Saal Brünig
Minimally Invasive Repair of Incisional Hernia
Ulrich Dietz, Solothurn    
1630-1650
Saal Brünig
Complications after Hernia Repair
Markus Schäfer, Lausanne    
1715-1815
Theatersaal
GA SGGSSG
1815-1900
Theatersaal
GA SASL
1815-1900
Kongresssaal
GA MDL
1815-1900
Saal Brünig
GA IBDNet
1815-1900
Saal Harder
GA SwissNGM

Friday, 13.9.2019

0830-1000
Theatersaal
Gastroenterology: Rapid Fire Answers to hot topics
Sébastien Godat, Lausanne    Christoph Gubler, Zürich    Carlo Valli, Visp    
0830-0845
Theatersaal
Bile duct stone: papillotomy, balloon or both?
Jean-Louis Frossard, Genève    
0845-0900
Theatersaal
Antithrombotic agents and polypectomy: news?
Nico Wiegand, Luzern    
0900-0915
Theatersaal
Colon polyp in the old patient: resection, biopsy, watch and wait?
Kaspar Truninger, Langenthal    
0915-0930
Theatersaal
Eosinophilic esophagitis: treatment strategy
Alain Schoepfer, Lausanne    
0930-0945
Theatersaal
How to perform balloon dilatation in Achalasia?
Radu Tutuian, Solothurn    
0945-1000
Theatersaal
How to identify IM in the stomach and follow-up
Jan Borovicka, St.Gallen    
0830-1000
Kongresssaal
SASL Hot Topics: Hepatitis D, NAFLD and TIPPS
Andrea De Gottardi, Bern    Francesco Negro, Genève    
0830-0900
Kongresssaal
Hepatitis D: unsolved issues
Mario Rizzetto, Torino    
0900-0930
Kongresssaal
NAFLD-HCC: specificities in diagnosis and management
Jean-François Dufour, Bern    
0930-1000
Kongresssaal
Early/preemptive TIPPS in patients with cirrhosis and variceal bleeding
Juan Carlos Garcia-Pagán, Barcelona    
0830-1000
Saal Brünig
SGVC free communications
Frédéric Ris, Genève    Bruno Schmied, St. Gallen    
0830-0840
Saal Brünig
Assessment of radiological rectal cancer restaging after chemoradiotherapy
Andreas Kohler, Bern    
0840-0850
Saal Brünig
Meta-analysis of randomized controlled trials of surgery for rectal cancer
Georgios Peros, Winterthur    
0850-0900
Saal Brünig
Survival after hepatectomy for colorectal liver metastases is a function of intrahepatic recurrence but is not dependent of recurrence at the liver resection margin: a bicentric experience
Andreas Andreou, Bern    
0900-0910
Saal Brünig
Single cell RNA-seq Atlas of a Regenerating Liver in Mice
Daniel Sánchez-Taltavull, Bern    
0910-0920
Saal Brünig
Minimal-Invasive Versus Open Hepatectomy for Colorectal Liver Metastases: Bicentric Analysis of Postoperative Outcomes and Long-Term Survival Using Propensity Score Matching Analysis
Andreas Andreou, Bern    
0920-0930
Saal Brünig
Inherited polymorphic p53 response elements in the human genome interact with somatic p53 mutations to affect patient survival: a pan-cancer analysis
Lukasz Filip Grochola, Winterthur    
0930-0940
Saal Brünig
Minimal length of proximal resection margin in adenocarcinoma of the esophagogastric junction: a systematic review of the literature
Nadja Niclauss, Genève    
0940-0950
Saal Brünig
4 years experience of robotic-assisted (da Vinci Xi) giant hiatal hernia repair: feasibility, quality and comparison to the standard laparoscopic approach
Alexander Wilhelm, Basel    
0950-1000
Saal Brünig
Laparoscopic surgery for gastric cancer: the European point of view
Mickael Chevalley, Genève    
1000-1030
Exhibition Area
Coffee break
1030-1200
Theatersaal
SGG-SGVC-GESKES Joint Session: Nutrition for everybody
Andrew Macpherson, Bern    Rémy Meier, Liestal    Ralph Peterli, Basel    
1030-1050
Theatersaal
Microbiom and stool transplantation
Herbert Tilg, Innsbruck    
1050-1110
Theatersaal
Monitoring of Nutrition in patients with impaired resorption
Reinhard Imoberdorf, Winterthur    
1110-1130
Theatersaal
Low Fodmap diet- past hype, still hope?
Claudia Krieger-Grübel, St. Gallen    
1130-1150
Theatersaal
Nutrition in liver cirrhosis (ESPEN/EASL Guidelines)
Laurence Genton, Genève    
1200-1230
Exhibition Area
Lunch break
1230-1315
Theatersaal
Lunch Symposium AbbVie: Improve your skills in IBD management: Case-based discussions
1230-1315
Kongresssaal
Lunch Symposium Vifor Pharma Suisse: The Gastro Cruise: Zürich-New York direct/Panama strait/Welcome to the jungle
1230-1315
Saal Brünig
Lunch Symposium Norgine AG: NEW ALLY IN COLON CANCER PREVENTION?
1230-1315
Saal Harder
Lunch Symposium Takeda Pharma AG: The future is now - Innovative Surgical Procedures for the treatment of perianal fistula in Crohn's Disease
1330-1500
Theatersaal
Endoscopy Video session: How I do it
Sébastien Godat, Lausanne    Reiner Wiest, Bern    
1330-1500
Theatersaal
Video Session Polypectomy
Lukas Degen, Basel    Patrick Aepli, Luzern    Gian Dorta, Lausanne    Hans-Dieter Allescher, Garmisch-Partenkirchen    
1330-1500
Kongresssaal
GESKES Session: Nutrition, Resorption and Perception
Peter Ballmer, Winterthur    Claudia Heidegger, Genève    
1330-1350
Kongresssaal
Proteins for the surgical patient
Martin Hübner, Lausanne    
1350-1410
Kongresssaal
Effort Study update
Philipp Schütz, Aarau    
1410-1430
Kongresssaal
Pharmacology: Resorption of drugs in postoperative patients
Markus Lampert, Solothurn    
1430-1450
Kongresssaal
Food image understanding: How close can we get?
Zeno Stanga, Bern    
1330-1500
Saal Brünig
SGVC: Rapid Fire Answers to hot topics
Pietro Majno-Hurst, Lugano    Carsten Thomas Viehl, Biel-Bienne    
1330-1340
Saal Brünig
Ta TME or Robotic which way to go to the Rectum
Nicolas Buchs, Genève    
1340-1350
Saal Brünig
Treatment of Mucinous Neoplasms of the Appendix
Kuno Lehmann, Zürich    
1350-1400
Saal Brünig
Sense or Nonsense of Laparoscopic Whipple Procedure: Pro
Stefan Breitenstein, Winterthur    
1400-1410
Saal Brünig
Sense or Nonsense of Laparoscopic Whipple Procedure: Contra
Nermin Halkic, Lausanne    
1410-1420
Saal Brünig
Treatment of GERD: New Tools for an old Disease?
Yves Borbély, Bern    
1420-1430
Saal Brünig
Modern treatment of Anal Fistula
Dimitri Christoforidis, Lugano    
1430-1440
Saal Brünig
HIPEC, PIPAC or Cytoreductive Surgery alone
Martin Hübner, Lausanne    
1500-1530
Exhibition Area
Coffee break
1530-1700
Theatersaal
SGG-SGVC Joint Session: Grande Finale
Peter Bauerfeind, Zürich    Markus Weber, Zürich    
1530-1550
Theatersaal
Pancreas Cancer: new diagnostic tools, surveillance of patients at risk
Julia Mayerle, München    
1550-1600
Theatersaal
Discussion
Daniel Candinas, Bern    
1600-1620
Theatersaal
Endoscopic resection of early cancer: strategy in patients with high risk histology
Alexander Meining, Ulm    
1620-1630
Theatersaal
Discussion
Markus von Flüe, Basel    
1630-1650
Theatersaal
Endoscopic therapy of functional disorders
Horst Neuhaus, Düsseldorf    
1650-1700
Theatersaal
Discussion
Magnus Paul Schneider, Zürich    
1530-1700
Saal Brünig
GESKES: Abschlussvorträge des ZKE Lehrganges
Reinhard Imoberdorf, Winterthur    Andrea Kopp-Lugli, Basel    
1715-1800
Saal Brünig
GA GESKES

Posters

Gastroenterology

G1Diaphragm Disease im Colon ascendens ohne Einnahme von nichtsteroidalen Antirheumatika – ein Fallbericht
Robert Bauer (1) Urs Pfefferkorn(2)
(1) Chirurgische Klinik, Kantonsspital Baselland, Liestal (2) Chirurgische Klinik, Solothurner Spitäler AG, Olten
G2Feasibility of cecal retroflexion in screening colonoscopy with Endocuff
Mikael Sawatzki (1), Jan Borovicka (1), Stephan Baumeler (1)
1 Division of Gastroenterology/ Hepatology, Kantonsspital St. Gallen, Switzerland
G3A rare case of gastric outlet obstruction in a patient with multiple myeloma
Rahel Haeuptle (1), Christoph Driessen (2), Jan Borovicka(1), Mikael Sawatzki (1)
1 Division of Gastroenterology, Kantonsspital St.Gallen, Switzerland 2 Division of Oncolocy, Kantonsspital St.Gallen, Switzerland
G4“Spontaneous” bowel perforation caused by oral preparation for colonoscopy
Mikael Sawatzki (1), Samuel Henz (2), Rebecca Schiefer (2), Roland Hausmann (3), Jan Borovicka (1)
1 Division of Gastroenterology, Kantonsspital St. Gallen, Switzerland 2 Department of Internal Medicine, Spital Rorschach, Switzerland 3 Institute of Legal Medicine, Kantonsspital St. Gallen, Switzerland
G5The intra-individual Variability of Fecal Calprotectin in healthy individuals
Seraina Netzer Peter Netzer
Gastrozentrum Netzer AG, Bremgartenstrasse 115, 3012 Bern Lindenhofspital Bern, Bremgartenstrasse 117, 3001 Bern
G6Audit of colon polyps’ surveillance programme in daily clinical practice
Seraina Netzer Peter Netzer
Gastrozentrum Netzer AG, Bremgartenstrasse 115, 3012 Bern Lindenhofspital Bern, Bremgartenstrasse 117, 3001 Bern
G7Fulminant Ulcerative Colitis initially presenting as Bullous Pyoderma Gangrenosum: a case report and review of literature
Joseff Karl Fernandez (1), Ira Yu (1)
(1) National Kidney and Transplant Institute; Philippines
G8Endoscopic full-thickness resection (FTRD) of a non-ampullary lesions of the proximal duodenum in a 67 year old patient with attenuated polyposis coli
Breidert Matthias (1), Anliker Oliver (1), Töpfer Antonia (2), Tajasev Vitali (1), Sieweke Wolfram (1)
(1)Dept. of Gastroenterology/Hepatology, City Hospital Waid and Triemli, Location Waid, 8037 Zürich (2)Institute of Pathology, University of Zürich, 8091 Zürich
G9Ustekinumab (UST) Induced Clinically Meaningful Improvement and Remission as Measured by the Inflammatory Bowel Disease Questionnaire (IBDQ) in Patients with Moderate to Severe Ulcerative Colitis
Colleen Marano(1), Bruce E Sands(2), Chenglong Han(3), Hongyan Zhang(1), Jewel Johanns(1), Philippe Szapary(1), Rupert W Leong(4), Silvio Danese(5)
(1)Janssen R&D, Spring House, USA; (2)Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA; (3)Janssen Global Services, Malvern, USA; (4)Concord and Macquarie University Hospitals, Sydney, Australia; (5)Humanitas Research Hospital, Milano, Italy
G10Effects of Ustekinumab (UST) Induction Therapy on Endoscopic and Histologic Healing in Ulcerative Colitis
Colleen Marano(1), Katherine Li(1), Joshua R Friedman(1), Hongyan Zhang(1), Feifei Yang(1), Brian G Feagan(2), Laurent Peyrin-Biroulet(3), Gert De Hertogh(4)
(1)Janssen R&D, Spring House, USA; (2)Robarts Clinical Trials, Robarts Research Institute, Western University, London, Ontario, CA; (3)Nancy University Hospital, Université de Lorraine, Nancy, FR; (4)University Hospitals KU Leuven, BE
G11Efficacy and Safety of Ustekinumab Through Week 16 in Patients with Moderate to Severe Ulcerative Colitis
Colleen Marano(1), Silvio Danese(2), Bruce E Sands(3), Christopher D O’Brien(1), Hongyan Zhang(1), Jewel Johanns(1), Sheldon Sloan(1), James Izanec(1), Philippe Szapary(1), Rupert Leong(4), David Rowbotham(5), Stephan Targan(6), Gert Van Assche(7)
(1)Janssen R&D, USA; (2)Humanitas Research Hospital, IT; (3)Icahn School of Medicine, USA; (4)Concord and Macquarie University (U) Hospitals, AU; (5)Auckland City Hospital, NZ; (6)Cedars Sinai Medical Center, USA; (7)U of Leuven, BE
G12Efficacy of Ustekinumab (UST) in Moderate-Severe Ulcerative Colitis (UC) in Biologic Failure (BF) and Nonbiologic-Failure (NBF) Populations
C. Marano(1), B.E. Sands(2), L. Peyrin-Biroulet(3), C.D. O’Brien(1), H. Zhang(1), J. Johanns(1), P. Szapary(1), D. Rowbotham(4), R.W. Leong(5), R.P. Arasaradnam(6), S. Danese(7), G. van Assche(8), S. Targan (9), W.J. Sandborn(10)
(1)Janssen R&D, USA; (2)Icahn School of Medicine at Mount Sinai, USA; (3)Nancy University (U) Hospital, FR; (4)Auckland City Hospital, NZ; (5)The U of New South Wales and Macquarie U, AU; (6)Warwick Medical School, UK; (7)Humanitas Research Hospital, IT; (8)U of Leuven, BE; (9)Cedars Sinai Medical Center, USA; (10)U of California San Diego, USA
G13Efficacy and Safety of Ustekinumab (UST) as Maintenance Therapy in Ulcerative Colitis: Week 44 Results from UNIFI
C. Marano(1), W.J. Sandborn(2), B.E. Sands(3), R. Panaccione(4), C.D. O’Brien(1), H. Zhang(1), J. Johanns(1), L. Peyrin-Biroulet(5), G. van Assche(6), S. Danese(7), S. Targan(8), M.T. Abreu(9), T. Hisamatsu(10), P. Szapary(1)
(1)Janssen R&D, Spring House; (2)University (U) of California San Diego, La Jolla; (3)Icahn School of Medicine at Mount Sinai, New York; (4)U of Calgary, Calgary; (5)Nancy U Hospital, Nancy; (6)U of Leuven, Louvain; (7)Humanitas Research Hospital, Milan; (8)Cedars Sinai Medical Center, Los Angeles; (9)U of Miami Miller School of Medicine, Miami; (10)Kyorin U, Tokyo
G14First experiences with ESD + in a 3 cm rectal polyp. A case study at the Stadtspital Waid, Zurich
Breidert M, Tajasev V, Locher R, Zellweger M
Stadtspital Waid
G15Prospective Study of Risk Score Strategies in the Prediction of Advanced Colorectal Neoplasia at Colonoscopy
Bianca So (1) Yunki Yau (1, 2) Viraj Kariyawasam (1, 2) Rupert W. Leong (1, 2, 3)
(1) Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia (2) Gastroenterology and Liver Services, Concord Repatriation General Hospital, Sydney, NSW, Australia (3) Sydney Medical School, University of Sydney, Sydney, NSW, Australia
G16Oeso-mediastinal fistula complicating tuberculosis and cervical lymp node involvement
S.Guglielmi(1), G.Guglielmi(2), S.Mönig(3), J-P Janssen(4), L.Spahr(1). 1:Gastroenterolology, 2:Radiology, 3:Visceral Surgery, 4:Pneumology, HUG
Hôpitaux Universitaires de Genève
G17Phytobezoar causing gastric outlet obstruction as a late complication after biliopancreatic diversion with duodenal switch
Simone Zwicky (1,4), Urs Pfefferkorn (1,2,4), Werner Inauen (3,4,5)
(1)Department of Surgery, Bürgerspital Solothurn, (2)Department of Surgery, Kantonsspital Olten (3)Clinic for Gastroenterology and Hepatology, Bürgerspital Solothurn (4)Solothurner Spitäler AG, Switzerland (5)University of Bern, Switzerland
G18VIDEO - Endoscopic intra-abdominal rescue therapy of a dislodged EUS-guided hepaticogastrostomy stent
Johannes Maubach, Andrew J. Macpherson
Department of Visceral Surgery and Medicine, University Clinic of Bern, Inselspital, Bern
G19VIDEO - Endoscopic rescue therapy of a distally perforated, retroperitoneal stent after EUS-guided pancreaticogastrostomy
Johannes Maubach, Andrew J. Macpherson
Department of Visceral Surgery and Medicine, University Clinic of Bern, Inselspital, Bern
G20Microbial and Metabolic Profile of Longitudinally Sampled Colorectal Cancer Patients
Bahtiyar Yilmaz (1,2), Deborah Morgenthalers(1,2), Ruben Mars(3), Lukas Brügger(2), Andreas Kohler(2), Uwe Sauer(3), Andrew J. Macpherson(1,2), and Peter Studer(2)
(1) Department for Biomedical Research (DBMR), University of Bern, Bern, Switzerland (2) Uni. Hospital Visceral Surgery and Medicine, Inselspital Bern, Bern, Switzerland (3)Swiss Federal Institute of Technology (ETH) Zürich, Zürich, Switzerland
G21Healing earth is an effective therapeutic option in patients with NERD
Thomas Orth (1), Hubert Mönnikes (2)
(1) Gesundheitszentrum Orth & Orth, Eltville, Germany; (2) Klinik für Innere Medizin, Martin-Luther-Krankenhaus, Berlin, Germany
G22EUS-guided hepaticogastrostomy (HGS) with transgastric cholangioscopy (tPOCS) and metal stent insertion for a distal common bile duct (CBD) stenosis in a patient with chronic pancreatitis
Hans Entzian, Andrew J. Macpherson, Mathias Worni, Johannes Maubach
Department of Visceral Surgery and Medicine, University Clinic of Bern, Inselspital, Bern
G23An Unusual Subepithelial Tumor of Duodenum
Mentor Bilali 1,2, Bernhard Morell 1,2, Matteo Montani 3, Kaspar Truninger 2, Christoph Gubler 1,2 1 Division of Gastroenterology & Hepatology, University Hospital Zurich, Zurich, Switzerland 2 Division of Gastroenterology, Regional Hospital of Oberaa
1 Division of Gastroenterology & Hepatology, University Hospital Zurich, Zurich, Switzerland 2 Division of Gastroenterology, Regional Hospital of Oberaargau SRO, Langenthal, Switzerland
G24Endoscopic control interferes with EndoFLIP measurements
Amanda Bianca(1), Valeria Schindler(1,2), Larissa Schnurre(1), Fritz Murray(1), Daniel Runggaldier(3), Daniel Pohl(1)
(1) Division of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland. (2) Division of Internal Medicine, Stadtspital Triemli, Zurich, Switzerland. (3) Department of Otorhinolaryngology, University Hospital of Zurich, Switzerland
G25Association between histological indices and ulcerative colitis (UC) activity measures among patients in the HICKORY (etrolizumab) open-label induction cohort
F. Seibold (1), L. Peyrin-Biroulet (2), B. Feagan (3), R.K. Pai (4), A. Boruvka (5), Y.S. Oh (6), A. Scherl (6), A. Scalori (7), P. Arrisi (8), S. Tole (6), D. T. Rubin (9)
(1) Crohn-Colitis Zentrum, Bern and Fribourg, Switzerland; (2) Université de Lorraine, France; (3) University of Western Ontario, Canada; (4) Mayo Clinic Phoenix, USA; (5) Roche Pharma Mississauga, Canada; (6) Genentech, Inc., South San Francisco, USA; (7) Roche Products Limited, Welwyn Garden City, UK; (8) F. Hoffmann-La Roche AG, Basel, Switzerland; (9) University of Chicago Medicine, IL, USA
G26Malignant granular cell tumor (GCT) in the oesophagus - rare and difficult to diagnose
Dominic Staudenmann1, Rupert Langer2, Yara Banz2, Andrew Macpherson1, Ives Borbély1, Reiner Wiest1
1 Department of Visceral Surgery and Medicine, University Clinic of Bern, 2 Institute of Pathology, University Hospital, Bern
G27Endoscopic submucosal dissection and unroofing of a symptomatic antral duplication cyst. A case-report.
Ansgar Deibel, Frans Oliver The, Christoph Gubler, Simon Bütikofer
Department of Gastroenterology and Hepatology, University Hospital Zurich
G28Endobiliary Radiofrequency Ablation (ELRA) for Malignant Billiary Obstruction over 24 months follow-up
Stefan H. Schlosser Adrian Casty Peter Netzer
Gastrozentrum Netzer and Lindenhof-Spital, Bern
G29Diagnosis of Gastric Cancer in the Excluded Stomach after Roux-en-Y Gastric Bypass by Jejunogastrostomy
Luca Schneider(1), Arne Kröger(1), Christoph Gubler(2), Frans O. The(2)
(1)Department of Internal Medicine, See-Spital, Horgen, Switzerland (2)Department of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland
G30Rescue EUS-guided gastro-pancreaticogastrostomy after failed transgastric ERP in a patient with obstructive chronic pancreatitis in the pancreatic head
Davide Lanza, Andrew Macpherson, Mathias Worni, Johannes Maubach
Department of Visceral Surgery and Medicine, University Clinic of Bern, Inselspital, Bern
G31Endoscopic ultrasound-directed transgastric ERCP (EDGE) in a patient with choledocholithiasis after Roux-en-Y gastric bypass (RYGB) and inadvertently interposed colon
Thrasyvoulos Gkrezios, Stephan Christen, Andrew J. Macpherson, Mathias Worni, Johannes Maubach
Gastroenterology, Clinic for Visceral Surgery and Medicine, University Hospital of Bern, Inselspital, Bern
G32HyperCkemia in IBD patients is TNF class-independent
Manuel Sutter1,2, Petr Hruz1, Jan Hendrik Niess1,2
1Department of Biomedicine, University Hospital Basel, University of Basel, Switzerland 2University Center for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital, Basel, Switzerland
G33The Branched-Chain Amino Acid Transporter CD98 Heavy Chain Supports the Development of Colonic Macrophages
Philipp Wuggenig1, Berna Kaya1, Hassan Melhem1, Korcan Ayata1, Petr Hruz2, Julien Roux1,3, Jan Hendrik Niess1,2
1Department of Biomedicine, University Hospital Basel, University of Basel, Switzerland. 2University Center for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital, Basel, Switzerland. 3Swiss Institute of Bioinformatics, Basel, Switzerland
G34Sloughing oesophagitis: a rare histologic and endoscopic finding
Riad Sarraj (1), Andrew J. Macpherson (1), Marion Bionda (1)
(1) Gastroenterology, Clinical for Visceral Surgery and Medicine, Bern University Hospital – Inselspital -, Bern
G35Endoscopic ultra-sonography guided drainage of the main pancreatic duct: a Swiss multi-center experience.
Sébastien Godat1*, Grégoire David1*, Robert Maxime1, Stefan Christen2, Johannes Maubach2.
1 Division of Gastroenterology and Hepatology, CHUV, Lausanne University Hospital 2 Division of Gastroenterology and Hepatology, Inselspital, Bern
G36First experience of gastric peroral endoscopic pyloromyotomy (GPOEM) in a Swiss university endoscopic unit.
Eleni Moschouri(1), Grégoire David(1), Maxime Robert(1), Sébastien Godat(1)
(1 Service de gastro-entérologie et d’hépatologie, Centre hospitalier universitaire vaudois, Lausanne)
G37Amebic liver abscess after first infusion of ustekinumab in a patient with colonic Crohn`s disease manifestation
Florian Rybinski1, Maja Weisser2, Jan Hendrik Niess1,Petr Hruz1
1Division of Gastroenterology & Hepatology, Clarunis, Basel, Switzerland 2Division of Infectious Diseases, University Hospital, Basel, Switzerland
G38Disease activity in patients with inflammatory bowel disease correlates with the serum copper/zinc ratio
Tobias Schneider (1), Daniel Caviezel (1), C. Korcan Ayata (1), Caroline Kiss (2), Jan Hendrik Niess (1), Petr Hruz (1)
(1) Division of Gastroenterology & Hepatology, Clarunis, Basel, Switzerland (2) Division of Dietetics and Nutrition, University Hospital Basel, Switzerland
G39Endoscopic removal of multiple ingested batteries using a strong magnet
Werner Inauen (1,2), Bruno Loosli (1), Felix Brunner (1), Sandra Capraru (1), Brindusa Diaconu (1), Markus Herzig (1), Michaela Neagu (1), Radu Tutuian (1,2,3)
(1) Clinic for Gastroenterology and Hepatology, Bürgerspital Solothurn, Solothurner Spitäler AG, Switzerland (2) University of Bern, Switzerland (3) University of Zurich, Switzerland
G40Endoscopic treatment of large esophageal leaks
Mariola Marx1*, Maxime Robert 1*, Grégoire David1, Sébastien Godat1 1 Division of Gastroenterology and Hepatology, Lausanne University Hospital
Division of Gastroenterology and Hepatology, Lausanne University Hospital
G41Spontaneus intramural esophageal dissection (IOD): a case report
Patrik Dolliana, Henriette Heinrich, Peter Bauerfeind
Department of Gastroenterology Stadtspital Triemli, Zurich
G42Chenodeoxycholic-acid induced vascular endothelial cell activation: effects on VE-cadherin and endothelial permea-bility
S. Vukovic(1), R. Sfriso(1), M. Sorribas(1), R. Rieben(1),R. Wiest(1,2)
1Department for Biomedical Research, University of Bern, 2Department of Visceral Surgery & Medicine, Bern University Hospital, Bern, Switzerland.
G43Colon Modeling Open Source Tool (CMOST) for modeling of the natural history of colorectal cancer
(1) Benjamin Misselwitz (2) Ansgar Deibel
(1) Inselspital Bern (2) UniversitätsSpital Zürich
G44Close follow-up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long-term management of eosinophilic esophagitis
Thomas Greuter (1), Ekaterina Safroneeva (2), Christian Bussmann (3), Michael Donovan (4), Luc Biedermann (1), Alain M. Schoepfer (5), Talaya McCright-Gill (4), Gabriela N. Mendoza (4), Alex Straumann (1) and Mirna Chehade (4)
1 University Hospital Zurich; 2 University of Bern; 3 Pathology Viollier AG, Basel; 4 Icahn School of Medicine at Mount Sinai, New York, United States of America; 5 University Hospital Lausanne – (CHUV)

Hepatology

H1Upper gastrointestinal ulcerations with granulomatous hepatitis and bilateral adrenal masses after Thailand travelling
Mikael Sawatzki (1), Christina Lins (2), Christian Bucher (3), Philipp Kohler (4)
1 Division of Gastroenterology/Hepatology, Kantonsspital St.Gallen, St.Gallen, Switzerland 2 Department of Internal Medicine, Spital Rorschach, Rorschach, Switzerland 3 Division of Nephrology, Kantonsspital St.Gallen, St.Gallen, Switzerland 4 Division of Infectious Diseases, Kantonsspital St.Gallen, St.Gallen, Switzerland
H2Usefulness of contrast-enhanced ultrasound evaluating focal steatosis in the liver of cystic fibrosis – A case report in a cirrhotic and non-cirrhotic liver – Video Session
Mikael Sawatzki (1), David Semela (1), Martin Brutsche (2)
1 Division of Gastroenterology/Hepatology, Kantonsspital St. Gallen, Switzerland 2 Department of Pneumology, Kantonsspital St. Gallen, Switzerland
H3Illustrations to support patient counseling before and after liver transplantation
Patrizia Künzler-Heule(1), Andrea Pfister-Koch(2), Irina Bergamin(1), Sonja Beckmann(3)
(1) Clinic for Gastroenterology/Hepatology, Cantonal Hospital St. Gallen, St. Gallen; (2) Department of Abdomen and Metabolism and (3) Zentrum für Klinische Pflegewissenschaft, University Hospital Zurich, Zurich
H4Regulation of lymphangiogenesis by Paneth cells in normal physiology and experimental portal hypertension
Mohsin Hassan(1), Andrea De Gottardi (1, 2) , Sheida Moghadamrad (1, 2)
1)Department of Biomedical Research, Hepatology, University of Bern 2)Department of Visceral Surgery and Medicine, Inselspital, University Hospital of Bern, Switzerland
H5Quality of life measurement using wrist actigraphy in HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving ombitasvir, paritaprevir, and ritonavir tablets and dasabuvir tablets (Viekirax®/Exviera®; 3D regimen): The HEMATI
Nasser Semmo(1), Beat Müllhaupt(2), Lisa Ruckstuhl(3), Lorenzo Magenta(4), Olivier Clerc(5), Ralph Torgler(3), David Semela(6)
(1) Hepatology, Department of BioMedical Research, University of Bern, Bern, CH. (2) Division of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, CH. (3) AbbVie Schweiz AG, Baar, CH. (4) Epatocentro Ticino, Lugano, CH. (5) Infectious Diseases Department, Hospital Pourtalès, Neuchâtel, CH. (6) Division of Gastroenterology, Kantonsspital St. Gallen, St. Gallen, CH
H6Early outcome in patients with non-alcoholic fatty liver in comparison with non-alcoholic steatohepatitis undergoing gastric bypass: a propensity score matched analysis
Z. Abbassi, SD Sgardello, S. Naiken, N. Niclauss, M. Chevallay, J. Meyer, SP. Mönig, C. Toso, ME. Hagen, MK Jung
University Hospital of Geneva and medical School
H7A buyers’ club to improve access to hepatitis C and HIV treatment for vulnerable populations
Vernaz Nathalie (1,2), Calmy Alexandra (3), Hurst Samia (4), Jackson Yves (5), Negro Francesco (6), Perrier Arnaud1, Anne-Claire Bréchet (7), Laurent Gétaz (7), Wolff Hans (7)
(1) Medical Direction, (2) Finance Direction, (3) HIV Unit, (3) Infectious Disease division, (4) Institute for Ethics, (4) History, and the Humanities, (5) Division of primary care medicine, (6) Divisions of Gastroenterology and Hepatology and of Clinical Pathology, (7) Division of Prison Health, Geneva University Hospitals, University of Geneva, Switzerland
H8Evaluation of the prognostic value of histologic parameters in severe alcoholic hepatitis
Margaux Dubois (1), Amedeo Sciarra (2), Astrid Marot (3), Christine Sempoux (4), Pierre Deltenre (4,5)
(1) Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland (2) Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland (3) Department of Gastroenterology and Hepatology, CHU UCL Namur, Université Catholique de Louvain, Yvoir, Belgium (4) Department of Gastroenterology, Hepatopancreatology, and Digestive Oncology, C.U.B. Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium (5) Department of Gastroenterology and Hepatology, Clinique St Luc, Bouge, Belgium
H9Robust MAIT cell activation in response to interactions with primary human liver cell subsets
Martin J. Lett(1), Adrian Keogh(2), Tina Jaeger(1), Marie-Anne Meyer(3,4), Isabel Fofana(3), Markus H. Heim(3,4), Deborah Stroka(2), Magdalena Filipowicz Sinnreich(1,5)
(1)Liver Immunology, Department of Biomedicine, University Hospital Basel and University Basel, (2)Clinic of Visceral Surgery and Medicine, Department of Clinical Research, University Hospital Bern, (3)Hepatology, Department of Biomedicine, Basel, (4)Gastroenterology and Hepatology, University Hospital Basel, (5)Gastroenterology and Hepatology, Basel University Medical Clinic, Liestal
H10Hepatic gene expression analysis identifies marked différences in acute alcoholic microvesicular steatosis compared to alcoholic steatohepatitis (ASH)
Nicolas Goossens (1), Laura Rubbia-Brandt(2), Nicolas Lanthier(3), Laurent Spahr(1)
(1) Gastroenterology and Hepatology, HUG; (2) Clinical Pathology,HUG;(3) Hepatology, ULB Bruxelles
H11Loss of Claudin-3 Results in Metabolic Reprogramming and Impaired Regeneration in the Murine Liver
Felix A. Baier(1), Daniel Sánchez-Taltavull(1), Fadi Jebbawi(1), Nicolas Melin(1), Adrian Keogh(1), Ramesh Kudira(1), Mariana Dias(2), Urban Deutsch(2), Mikio Furuse(3), Guido Beldi(1), Britta Engelhardt(2), Daniel Candinas(1), Deborah Stroka(1)
(1) Visceral Surgery and Medicine, Department of Biomedical Research, University of Bern and Inselspital Bern, Switzerland (2) Immunobiology Research group, Theodor Kocher Institute Bern (3) Division of Cell Structure, National Institute for Physiological Sciences, Japan
H12Thrombin generation in patients with liver cirrhosis: modern global hemostasis assays provide new insights into a procoagulant state
Maxime G. Zermatten (1), Montserrat Fraga (2), Debora Bertaggia Calderara (1), Alessandro Aliotta (1), Darius Moradpour (2), Lorenzo Alberio (1)
(1) Division and Central Laboratory of Hematology as well as (2) Division of Gastroenterology and Hepatology, Lausanne University Hospital (CHUV), Lausanne, Switzerland
H13What if increased INR and aPTT would represent a thrombotic instead of a bleeding risk in cirrhotic patients?
Maxime G. Zermatten (1), Montserrat Fraga (2), Debora Bertaggia Calderara (1), Alessandro Aliotta (1), Darius Moradpour (2), Lorenzo Alberio (1)
(1) Division and Central Laboratory of Hematology as well as (2) Division of Gastroenterology and Hepatology, Lausanne University Hospital, Lausanne, Switzerland
H14Out of Africa: Hepatitis C Virus Subtype 4r as Troublemaker
Sophie Cottagnoud(1), Adeline Mathieu(1), Matthieu Perreau(2), Darius Moradpour(1) and Montserrat Fraga(1)
(1)Service of Gastroenterology and Hepatology as well as (2)Service of Immunology and Allergy, CHUV, University of Lausanne
H15AXL-expressing immune-homeostatic liver macrophages disappear in progressive cirrhosis
Oltin T Pop(1,2)*, Robert G Brenig(1,3)*, Evangelos Triantafyllou(4,5), Patrizia Künzler(1), Stephan Brand(1), Julia A Wendon(4), Markus H Heim(3), David Semela(1), Charalambos G Antoniades(4,5), Luigi M Terracciano(6), Christine Bernsmeier(1,3)
(1)Gastroenterology&Hepatology,Cantonal Hospital,St.Gallen, (2)Institute of Immunobiology,Cantonal Hospital St. Gallen,(3)Gastroenterology&Hepatology,University Hospital,Basel,(4)King’s College London,UK,(5) Imperial College London,UK, (6)Pathology,University Hospital,Basel;(*contributed equally)
H16Autoimmune Idiopathic Disorders in HCV patients: Effect of Direct Antiviral Agents - the AIDAA study (SASL 42)
Giuseppe Murgia1, Annalisa Berzigotti1, Benedetta Terziroli2 Adriana Baserga3, David Semela4, Guido Stirnimann1
1Hepatologie, UVCM, Inselspital, Bern; 2Epatocentro Ticino, Lugano; 3Fondazione Epatocentro Ticino, Lugano; 4Klinik für Gastroenterologie/Hepatologie, Kantonsspital St. Gallen
H17ABCB4 deficiency associated Copper Overload mimicking Wilson’s disease: a Case report
Matthias C. Reichert(1), Vincent Zimmer(1), Frank Grünhage(1), Frank Lammert(1) and Christoph Jüngst (1,2)
(1)Department of Medicine II, Saarland University Medical Center, Homburg, Germany, (2)Department of Gastroenterology and Hepatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
H18Targeting the mitotic spindle assembly in patient-derived liver cancer organoids
Marie-Anne Meier (1,2), Sandro Nuciforo (1), Lauriane Blukacz (1), Xueya Wang (1), Sylvia Ketterer (1), Stefan Wieland (1), Markus Heim (1,2)
(1) Department of Biomedicine, University of Basel, Basel, Switzerland (2) Clarunis – Universitäres Bauchzentrum, Department of Gastroenterology and Hepatology, University Hospital of Basel, Basel, Switzerland
H19Liver disease following bone marrow transplantation : clinical and biological characteristics of sinusoidal obstruction syndrome (SOS) and graft-versus-host disease (GVH)
Ph.Mathys(1), N.Goossens (1), Y.Chalandon (2), L.Rubbia-Brandt (3), L.Spahr (1)
(1) Gastroenterology/Hepatology, (2) Oncohematology, (3) Clinical Pathology, Hôpitaux Universitaires de Genève (HUG)
H20Preliminary report on the Swiss Autoimmune Hepatitis Cohort Study
Emmanuela Pareti (1) Giacomo Maria Cioffi (2) Andreas Cerny (3) Stefania Casu (4) Christiane Sokollik (5) Christian Braegger (6) David Semela (7) Giorgina Mieli-Vergani (8) Diego Vergani (9) Benedetta Terziroli Beretta-Piccoli (3,9)
(1) Internal Medicine; Ospedale Beata vergine; Mendrisio; Switzerland (2) Cardiology Divison; Fondazione Cardiocentro Ticino; Lugano; Switzerland (3) Hepatology Department; Epatocentro Ticino; Lugano; Switzerland (4) Pankreas Zentrum; Inselspital; Bern; Switzerland (5) Pediatric gastroenterology; Hepatology and Nutrition Department; Inselspital; Bern; Switzerland (6) Gastroenterologie und Ernährung; Universitäts-Kinderspital; Zurich; Switzerland (7) Gastroenterologie und Hepatologie; Kantosspital St. Gallen; St. Gallen; Switzerland (8) Paediatric Liver, GI and Nutrition Centre; MowatLabs, King's College Hospital; London; UK (9) Institute of Liver Studies; MowatLabs, King's College Hospital; London; UK
H21Preliminary report on the Swiss Primary Biliary Cholangitis Cohort Study
Emmanuela Pareti (1) Giacomo Maria Cioffi (2) Andreas Cerny (3) Guido Stirnimann (4) Magdalena Filipowicz (5) Joachim Mertens (6) David Semela (7) Adriana Baserga (3) Stefano Bellentani (8) Benedetta Terziroli Beretta-Piccoli (3,9)
(1) Internal Medicine; Ospedale Beata vergine; Mendrisio; Switzerland (2) Cardiology Divison; Fondazione Cardiocentro Ticino; Lugano; Switzerland (3) Hepatology Department; Epatocentro Ticino; Lugano; Switzerland (4) Leberzentrum; Inselspital; Bern; Switzerland (5) Department Biomedizin, Kantonsspital Baselland, Liestal; Switzerland (6) Klinik für Gastroenterologie und Hepatologie, Universitätsspital; Zurich; Switzerland (7) Gastroenterologie und Hepatologie; Kantosspital St. Gallen; St. Gallen; Switzerland (8) Clinica Santa Chiara, Locarno; Switzerland (9) Institute of Liver Studies; MowatLabs, King's College Hospital; London; UK
H22Epidemiology of hepatocellular carcinoma linked to non-alcoholic fatty liver disease in the canton of Geneva between 1990-2014: a populational and prospective study
Myers S (1), Gkouvatsos G (2), Spahr L (2), Giostra E (2), Bascaron ME (2), Frossard JL (2), Fournier E (3), Neyroud I (3), Goossens N (1, 2).
(1) Faculty of Medicine, (3) Geneva Cancer Registry, University of Geneva. (2) Division of Gastroenterology and Hepatology, Geneva University Hospital
H23The gene signature-MELD score and alcohol consumption determine long-term prognosis of patients with severe alcoholic hepatitis
Pierre Deltenre1,2,3, Eric Trépo1,4, Naoto Fujiwara5, Nicolas Goossens5,6, Astrid Marot3,7, Margaux Dubois8, Laurent Spahr6, Jean Henrion4, Christophe Moreno1,4, Yujin Hoshida5
1Department of Gastroenterology, Hepatopancreatology, and Digestive Oncology, C.U.B. Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium. 2Department of Gastroenterology and Hepatology, Clinique St Luc, Bouge, Belgium 3Department of Gastroenterology and Hepatology, Hôpital de Jolimont, Haine-Saint-Paul, Belgium 4Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Brussels, Belgium. 5Division of Digestive and Liver Diseases. Department of Internal Medicine. University of Texas Southwestern Medical Center, Dallas, USA. 6Division of Gastroenterology and Hepatology, Geneva University Hospital, Geneva, Switzerland. 7Department of Gastroenterology and Hepatology, CHU UCL Namur, Université Catholique de Louvain, Yvoir, Belgium 8Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
H24Video Case - „Unusual presentation of recurrent, large and symptomatic focal nodular hyperplasia of the liver“
Pamela Meyer-Herbon1, Daniela Husarik2, Jörg Neuweiler3, Bruno Schmied4, David Semela1
1Department of Gastroenterology and Hepatology, Kantonsspital St. Gallen 2Department of Radiology and Nuclear Medicine, Kantonsspital St. Gallen 3Institute of Pathology, Kantonsspital St. Gallen 4Department of General and Visceral Surgery, Kantonsspital St. Gallen
H25Insulin resistance in Hepatitis C virus infection: Relative contribution from liver vs. extrahepatic sites
Diana Gomes (1)§, Giacomo Gastaldi (2)§, Philippe Schneiter (3), Xavier Montet (4), Luc Tappy (3), Cyril Sobolewski (4), Nicolas Goossens (5), Michelangelo Foti (4), Sophie Clément (6)*, and Francesco Negro (5, 6)* §*equal contribution
(1) Dpt of Pathology and Immunology, and (4) Cell Physiology and Metabolism, UNIGE; (3) Dpt of Physiology, UNIL, (2) Divisions of Endocrinology, (4) radiology, (5) Gastroenterology and Hepatology, and (6) Clinical Pathology, HUG
H26Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies
Dulce Alfaiate (1), Sophie Clément (2), Diana Gomes (1), Nicolas Goossens (3) and Francesco Negro (2, 3)
(1) Dpt of Pathology and Immunology, University of Geneva, (2) Division of Clinical Pathology, (3) Division of Gastroenterology and Hepatology, Geneva University Hospitals
H27Global real world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C patients: Integrated Analysis of 12 clinical practice cohorts
Alessandra Mangia(1); Scott Milligan(2); Mandana Khalili(3); Stefano Fagiuoli(4); Stephen D Shafran(5); Fabrice Carrat (6); Denis Ouzan(7); George Papatheodoridis(8); Alnoor Ramji(9); Sergio M Borgia(10); Heiner Wedemeyer(11); Losappio(1); Francisco Pérez
(1)Ospedale Casa Sollievo Della Sofferenza, San Giovanni Rotondo, ITALY. (2)Trio Health Analytics, La Jolla, CA, USA. (3)University of California San Francisco/San Francisco General Hospital, CA, USA. (4)Asst Papa Giovanni XXIII, Italy - Lombardia HCV Network (5)University of Alberta, Canada. (6)Sorbonne Université, Institut National de la santé et de la Recherche Médicale, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris ; Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Unité de Santé Publique, Paris, France & ANRS CO22 HEPATHER France. (7)Institut Arnault Tzanck, Saint-Laurent du Var, France. (8)Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, Laiko General Hospital of Athens, Greece. (9)University of British Columbia, Canada. (10)Infectious Diseases, William Osler Health System, Brampton, Ontario, Canada. (11)Leberstiftungs-GmbH Deutschland, Hannover, Germany; Department of Gastroenterology and Hepatology, Essen University Hospital, Germany. (12)Hospital Universitario NS Candelaria, Tenerife, Spain – HEPA-C Cohort. (13)Medstar Health Research Institute, Washington DC, USA. (14)CRC “A. M. and A. Migliavacca” Center for the Study of Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy. (15)St Vincent’s Hospital, Melbourne, Australia. (16)Medical Affairs, Gilead Sciences, Switzerland. (17)Medical Affairs, Gilead Sciences, Australia. (18)Medical Affairs, Gilead Sciences Europe Ltd. U.K. (19)Department of Gastroenterology and Hepatology, C.H.U. Pontevedra & IIS Galicia Sur, Spain – HEPA-C cohort.
H28A Phase 3 Study Comparing Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide With Continued TDF Treatment in Virologically Suppressed Patients With Chronic Hepatitis B: Week 48 Efficacy and Safety Results
Pietro Lampertico(1), Maria Buti(2), Scott Fung(3), Sang Hoon Ahn(4), Wan-Long Chuang(5), Won Young Tak(6), Alnoor Ramji(7), Chi-Yi Chen(8), Edward Tam(9), Ho Bae(10), Xiaoli Ma(11), John F. Flaherty(12), Anuj Gaggar(12), Audrey Lau(12), Becket Feierbach(
(1)Universita Degli Studi di Milano, Italy; (2)Hospital Universitari Vall d'Hebron, Barcelona, Spain; (3)Toronto General Hospital, Toronto, Ontario, Canada; (4)Yonsei University, Severance Hospital, Seoul, South Korea; (5) Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan; (6)Kyungpook National University Hospital, Daegu, South Korea; (7)GI Research Institute, Vancouver, British Columbia, Canada; (8)Chia-Yi Christian Hospital, Chia-Yi City, Taiwan; (9)LAIR Centre, Vancouver; (10)Asian Pacific Liver Center, Los Angeles, California, USA; (11)Hahnemann University Hospital, Philadelphia, Pennsylvania, USA; (12)Gilead Sciences, Inc., Foster City, California; (13)Gilead Sciences, Steinhausen, Switzerland; (14)Silicon Valley Research Institute, San Jose, California; (15)The Catholic University of Korea, Seoul; (16)King’s College Hospital, London, UK; (17)Asan Medical Center, Seoul; (18)The Chinese University of Hong Kong, China
H29A combination of the ACC inhibitor GS-0976 and the nonsteroidal FXR agonist GS-9674 improves hepatic steatosis, biochemistry, and stiffness in patients with non-alcoholic steatohepatitis
Eric Lawitz(1), Edward Gane(2), Peter Ruane(3), Robert Herring, Jr.(4), Ziad H. Younes(5), Paul Kwo(6), Jie Zhang(7), Catherine Jia(7), Jay Chuang(7), Bryan McColgan(7), Chuhan Chung(7), Mani Subramanian(7), Robert Myers(7), Ramon Thali(8), Michael Middl
(1)Texas Liver Institute, University of Texas Health San Antonio, San Antonio, United States; (2)Liver Unit, Auckland City Hospital, Auckland, New Zealand; (3)Ruane Clinical Research, Los Angeles, United States; (4)Quality Medical Research, Nashville, United States; (5)GastroOne, Germantown, United States; (6)Stanford University School of Medicine, Palo Alto, United States; (7)Gilead Sciences, Inc., Foster City, United States; (8)Gilead Sciences, Steinhausen, Switzerland; (9)University of California at San Diego, San Diego, United States; (10)University of California Berkeley, Berkeley, United States; (11)Cedars-Sinai Medical Center, Los Angeles, United States; (12)Pinnacle Clinical Research, San Antonio, United States
H30LIM Protein Ajuba Promotes Cancer Cell Proliferation and Survival in Hepatocellular Carcinoma
Noëlle Dommann (1), Jacopo Gavini (1), Daniel Sánchez-Taltavul (1), Tess Brodie (1), Michaela Medova (2), Magali Humbert (3), Mario Tschan (3), Daniel Candinas (1),Deborah Stroka (1)
(1)Visceral Surgery and Medicine, (2)Radiation Oncology, Department of Biomedical Research Bern, (3)Tumor Pathology, Institute of Pathology, University of Bern, CH
H31Look-back procedure to reach non-compliant and lost to follow-up HBV patients
S. Costantini*, C. Taiana*, B. Terziroli Beretta-Piccoli, A. Baserga, D. Hagara, A. Cerny, L. Magenta. * SC and CT contributed similarly to this study
Epatocentro Ticino, Lugano, Switzerland (all authors)
H32Lysosomal compartment dysregulation as a treatment strategy for hepatocellular carcinoma
Jacopo Gavini(1), Noëlle Dommann(1), Manuel O. Jakob(1), Adrian Keogh(1), Laure C. Bouchez(4), Sofia Karkampouna(2), Marianna Kruithof-de Julio(2), Michaela Medova(3), Yitzhak Zimmer(3), Daniel Candinas(1), Deborah Stroka(1), Vanessa Banz(1)
1- Department of Visceral Surgery and Medicine, Department for BioMedical Research, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland 2- Department of Urology, Department for BioMedical Research, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland 3- Department of Radiation Oncology, Department for BioMedical Research, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland 4- Glenmark Pharmaceuticals, Lausanne, Switzerland
H33Concurrent biliary toxoplasmosis and portal-hypertensive cholangiopathy: a rare cause of haemobilia
Francisco Bravo, Johannes Maubach, Reiner Wiest
Department of Surgery and Medicine, Bern university Hospital
H34REGENERATE: A Phase 3 International, Placebo-Controlled Study Evaluating Obeticholic Acid Treatment for NASH
Zobair Younossi1, Vlad Ratziu2, Jean-Francois Dufour3, Leigh MacConell4, Reshma Shringarpure4, Stephen Harrison5, Arun J. Sanyal6 on behalf of the REGENERATE Study Investigators
INSELSPITAL University Clinic for Visceral Surgery and Medicine (UVCM)/Hepatology Freiburgstrasse 18, 3010 Bern

Surgery

S1Efficiency of an integrated workflow with augmented reality in 3D laparoscopic liver resection: clinical evaluation of a new image guided surgery system
Gian Andrea Prevost (1), Benjamin Eigl (2), Iwan Paolucci (3), Matthias Peterhans (2), Stefan Weber (3), Guido Beldi (1), Daniel Candinas (1), Anja Lachenmayer (1)
1) Department of Visceral Surgery and Medicine, Inselspital, University of Bern, 3010 Bern 2) CAScination AG, Steigerhubelstrasse 3, 3008 Bern 3) ARTORG Center for Biomedical Engineering Research, University of Bern, 3010 Bern
S2VIDEO OF A LAPAROSCOPIC REPAIR OF A STRANGULATED OBTURATOR HERNIA
Marius Antonescu, Markus Debelic, Romain Schaller
Service de Chirurgie, Hôpital du Jura
S3Intraductal papillary neoplasia of the bile ducts - a rare diagnosis
Stéphanie F. Perrodin, MD, Vanessa Banz, MD-PhD, Prof. Daniel Candinas, Corina Kim-Fuchs, MD-PhD
Department of Visceral Surgery and Medicine, University Hospital Bern, Inselspital, 3010 Bern, Switzerland
S4Publication of surgery specific outcomes as quality indicator - time to get involved?
Raffaele Galli, Robert Rosenberg
Klinik für Chirurgie, Kantonsspital Baselland
S5Compliance to the Surgical Safety Checklist over time in late and early adopters
Romain L. Seppey (1), Antoine Oesch (1), Carsten T. Viehl (1)
(1) Department of Surgery, Hospital Center Biel/Bienne, Biel/Bienne, Switzerland
S6Laparoscopic treatment of enterolith bowel obstruction: 2 cases report.
Delgadillo Xavier (¹) - Ott Vincent (²) - Wuthrich Philippe (³)
(¹)Centre Médico Chirurgical Volta, rue de la Paix 152, 2300- La Chaux‑de‑Fonds. (²) Hôpital La Providence, Faubourg de l'Hôpital 81, 2000- Neuchâtel.(³) Clinique de Genolier, Route du Muids 3, 1272- Genolier - Switzerland.
S7Laparoscopic Extended Left Hepatectomy for Giant Haemangioma. Technical Strategies for Complex Liver Resection.
Lukasz Filip Grochola (1), Erik Schadde (1), Stefan Breitenstein (1)
(1) Department of Surgery, Cantonal Hospital Winterthur.
S8The other liver metastasis with a crucial impact on the prognosis
Marionna Cathomas (1), Paolo Abitabile (2), Rok Dolanc (2), Christine Glaser (2), Gieri Cathomas (3)
(1) Chirurgische Klinik, Spital Münsterlingen, Schweiz (2) Chirurgische Klinik, Gesundheitszentrum Fricktal, Rheinfelden und Laufenburg, Schweiz (3) Institut für Pathologie, Kantonsspital Baselland, Liestal, Schweiz
S9Colorectal cancer associated with schistosomiasis- a case report
Kim, Herzog (1) Matthias, Matter (2) Philippe, Glauser (1)
Department of Surgery, Spital Dornach, Switzerland (1) Institute of Pathology, Universitätsspital Basel, Switzerland (2)
S10Role of PKM2 in macrophage polarization during liver regeneration.
Nicolas Melin, Giulio Loforese, Joel Zindel,, Isabel Büchi, Tess M. Brodi, Daniel Sanchez-Taltavull, Daniel Candinas, Deborah Stroka.
Viseral Surgery and Medecine, Department for Biomedical Research, University of Bern
S11Robot-assisted gastric GIST resection: a single center experience
Wassmer CH1, Chevallay M1, Colucci N1, Buchs NC1, Morel P1, Jung M1, Mönig SP1
1 Visceral and Transplant Surgery, Department of Surgery, University Hospitals of Geneva, and Medical School, Geneva, Switzerland

Interdisciplinary